vimarsana.com
Home
Live Updates
Data for Quadruplet Therapies Could Alter Frontline SOC for Transplant-Ineligible Multiple Myeloma : vimarsana.com
Data for Quadruplet Therapies Could Alter Frontline SOC for Transplant-Ineligible Multiple Myeloma
Muhamed Baljevic, MD, FACP, discusses the investigation of frontline quadruplet therapies in transplant-ineligible multiple myeloma.
Related Keywords
Tennessee ,
United States ,
Muhamed Baljevic ,
Vanderbilt Ingram Cancer Center Protocol ,
Plasma Cell Disorders Research ,
Vanderbilt Ingram Cancer Center ,
Division Of Hematology Oncology ,
Hematology Oncology ,
Vanderbilt Amyloidosis Multidisciplinary Program ,
Vanderbilt Ingram Cancer Center Protocol Review ,
Monitoring System ,
Vanderbilt Stem Cell Transplant ,
Cellular Therapy ,
vimarsana.com © 2020. All Rights Reserved.